ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,511.40
-0.11%
S&P ASX All Technology
4,034.50
0.55%
Brent Oil
74.565
0.00%
US Dollar vs AUD
1.5949
0.00%
Bitcoin
96,619.18
0.07%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Alnylam Pharmace Dl 0001 (DUL) Share Price

Alnylam Pharmace Dl 0001

Alnylam Pharmace Dl 0001 (DUL)

TG
267.60
-0.20
(-0.07%)
Closed 08 February 8:00AM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
267.60
Bid
265.60
Offer
269.60
Volume
88
263.00 Day's Range 269.90
132.00 52 Week Range 280.00
Market Cap
34.515B
Previous Close
267.80
Open
269.50
Last Trade
49
@
267.1
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
139
Shares Outstanding
128,980,917
Dividend Yield
-
PE Ratio
-80.91
Earnings Per Share (EPS)
-3.41
Revenue
1.83B
Net Profit
-440.24M

About Alnylam Pharmace Dl 0001

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.alnylam.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Alnylam Pharmace Dl 0001 is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker DUL. The last closing price for Alnylam Pharmace Dl 0001 was 267.80 €. Over the last year, Alnylam Pharmace Dl 0001 shares have traded in a share price range of 132.00 € to 280.00 €.

Alnylam Pharmace Dl 0001 currently has 128,980,917 shares in issue. The market capitalisation of Alnylam Pharmace Dl 0001 is 34.54 € billion. Alnylam Pharmace Dl 0001 has a price to earnings ratio (PE ratio) of -80.91.

Ask ADVFN Intelligence (AI)

DUL Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.7-0.998890122087270.3270.3260.3999923263.75947422DE
438.917.0091823349228.7270.3228.744256.59141341DE
1225.910.715763343241.7270.3217139234.69377894DE
262811.6861435726239.6280200.1122241.27607599DE
52106.666.2111801242161280132147199.03096922DE
156136.95104.822043628130.65280113.5294192.19433787DE
260148.64124.949562878118.9628079.6957180.19941336DE

DUL - Frequently Asked Questions (FAQ)

What is the current Alnylam Pharmace Dl 0001 share price?
The current share price of Alnylam Pharmace Dl 0001 is 267.60 €
How many Alnylam Pharmace Dl 0001 shares are in issue?
Alnylam Pharmace Dl 0001 has 128,980,917 shares in issue
What is the market cap of Alnylam Pharmace Dl 0001?
The market capitalisation of Alnylam Pharmace Dl 0001 is EUR 34.54B
What is the 1 year trading range for Alnylam Pharmace Dl 0001 share price?
Alnylam Pharmace Dl 0001 has traded in the range of 132.00 € to 280.00 € during the past year
What is the PE ratio of Alnylam Pharmace Dl 0001?
The price to earnings ratio of Alnylam Pharmace Dl 0001 is -80.91
What is the cash to sales ratio of Alnylam Pharmace Dl 0001?
The cash to sales ratio of Alnylam Pharmace Dl 0001 is 19.48
What is the reporting currency for Alnylam Pharmace Dl 0001?
Alnylam Pharmace Dl 0001 reports financial results in USD
What is the latest annual turnover for Alnylam Pharmace Dl 0001?
The latest annual turnover of Alnylam Pharmace Dl 0001 is USD 1.83B
What is the latest annual profit for Alnylam Pharmace Dl 0001?
The latest annual profit of Alnylam Pharmace Dl 0001 is USD -440.24M
What is the registered address of Alnylam Pharmace Dl 0001?
The registered address for Alnylam Pharmace Dl 0001 is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Alnylam Pharmace Dl 0001 website address?
The website address for Alnylam Pharmace Dl 0001 is www.alnylam.com
Which industry sector does Alnylam Pharmace Dl 0001 operate in?
Alnylam Pharmace Dl 0001 operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMWChina Communications Services Corp
39.89 €
(7,219.27%)
152
3YBPostal Savings Bank of China
39.55 €
(6,838.60%)
3.7k
YUE1Yue Yuen Industrial Holdings Ltd
39.875 €
(1,763.32%)
3.12k
CJHCanSino Biologics Inc
7.256 €
(96.11%)
281
0ZBConverge Technology Solutions Corp
3.656 €
(53.68%)
75.08k
1RR1Rokmaster Resources Corp
0.003 €
(-76.00%)
6k
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
3.69k
POTAPortofino Resources Inc
0.0028 €
(-46.15%)
267.47k
D4GDataMetrex AI Ltd
0.0032 €
(-40.74%)
29.97k
8NI0Nikola Corp
0.4368 €
(-39.78%)
1.85M
M11First Graphene Limited
0.0458 €
(-16.73%)
3.19M
FMKEcograf Limited
0.0788 €
(18.32%)
2.41M
G7PAEnergy Transition Minerals Ltd
0.0492 €
(0.41%)
2.21M
3CPXiaomi Corporation
5.30 €
(5.37%)
2.19M
D7GNel ASA
0.198 €
(1.02%)
2.01M

Discussion

View Full Feed
Genz2 Genz2 4 minutes ago
https://www.teslarati.com/trump-administration-pauses-ev-infrastructure-expansion-program-heres-why/amp/
TSLA
gawti88 gawti88 4 minutes ago
probably 3c+
CEOS
NorCalTommy NorCalTommy 4 minutes ago
Hi Chico! Always great to hear from you our friend... I sure hope we get much better per Share price than you conservatively predict... to wait until '28 or '29 to get $24 out of this stock would really be disheartening...... Even tho the greasy SPAC evangelists (MaxZ and Skiluk) predicted that t
NB
janice shell janice shell 5 minutes ago
LOL!! But it sounds like a good family project.
band aid band aid 5 minutes ago
Give it a break you have been saying that for what seems forever. This is a piece of puppy poop. I am down at the train station trying to assess the damage due to rust on train. Toot Toot
BIEL
janice shell janice shell 6 minutes ago
Oh. I see you haven't read Project 2025. I didn't read all 900 pages, but what I did get through was very alarming indeed.
Aladdin Sane Aladdin Sane 7 minutes ago
Just had a Aha moment. All speculation on my part, so take it with a grain of salt.

- Shiladitya Sengupta (aka "Shila") is the founder of Vyome. He and Venkat are partners.
- Shila is also the founder of Alyssum Therapeutics
- Alyssum Therapeutics raised 26M in Series A
LICH
janice shell janice shell 7 minutes ago
Tonight, Trumpty says he'll be going after the military. As in the Pentagon:

https://defensescoop.com/2025/02/07/trump-directs-elon-musk-doge-review-pentagon-dod-spending/

Wasn't someone talking earlier about how awful the Chinese are? Perhaps Trump and Musk will just i
Dabeav Dabeav 8 minutes ago
It can’t stay above 7 for a few minutes! 10 by end of feb.that would be sweet!
FNMA
ignatiusrielly35 ignatiusrielly35 9 minutes ago
Can I assume that the Charlatan is still posting inexplicable charts without any cognizable prediction? "Here's a chart with blatantly obvious trend lines and a meme attached to it that says nothing. I speak in code so that nobody can fault me since I didn't actually say anything."

I
XRPUSD
getmoreshares getmoreshares 9 minutes ago
Financial Volume $ 32 LOL
MRNJ
Zorax Zorax 9 minutes ago
Turns out that Perplexity AI creates a library of your previous inquiries.

Well, it's ai and needs a data base to train on. It's in the disclaimer somewhere.
B402 B402 11 minutes ago
"Common Sense" Is Not So Common"

https://www.psychologytoday.com/us/blog/magical-enlightenment/202107/why-common-sense-is-not-so-common

Key points
Common sense is not reasoning, logic, intuition or innate. It is acquired, and is changing, since the contents of na
trade15 trade15 13 minutes ago
My wife got on the kick of wanting to make her own soybean milk and tofu. She would want me to bring back to Toronto fresh soybeans right off the combines during fall harvest. The only problem was that she forgot my warning that you have to extract the oil first from the raw beans before using them
lodas lodas 14 minutes ago
yo ron?????... 16 years and counting, with not one cent returned to former WAMU claims holders .....SAYS YOU ARE WRONG!!!!!....read the documents, JPM took possession of the TPS......Lodas
JPM
Ricco79 Ricco79 15 minutes ago
https://www.banking.senate.gov/newsroom/majority/scott-meets-with-fhfa-director-nominee-pulte

Okay, here it is. Then we wait for Booooooom.

$10 February
FNMA
Jackxkr Jackxkr 16 minutes ago
Brazil population 200 million, boom there is revenue. Maybe the chart will be turning in favor of investors, I think this is helluva news.
NWBO
crowin crowin 18 minutes ago
Trump fires Kennedy Center board members citing drag shows, appoints himself chairman
rapz rapz 19 minutes ago
Reconsideration, not Reconciliation.
Worth taking a chance at the Appeals court. Justices at the Appeals seem to know their stuff, from reading all precedents discussed in this case.
VPLM
michael702/ michael702/ 19 minutes ago
We have some big time powerful people on the stock now!
BLLB
urge2surge urge2surge 21 minutes ago
The designation purchasers suggests a buyout or reverse merger? Didn't find much on a tacid search. Best I can figure. No indications of the 2.5 financing but he did say it would take affect in January. 22k in advertising for the year so that explains the lack of advertising exposure.
Maybe
IDVV
blackhawks blackhawks 22 minutes ago
Trump is a vengeful chickenshit. The first time something happens to someone he's pulled security from there will be hell to pay, particularly if the harm is done by a pardoned 1/6 treason weasel.

Your Recent History

TG
DUL
Alnylam Pharmace Dl 0001
AMEX
BITQ
Bitwise Crypto Industry ...
TG
IP4
InnoCan Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads